Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population. / Orsted, David D; Nordestgaard, Børge G; Jensen, Gorm B; Schnohr, Peter; Bojesen, Stig E; Ørsted, David Dynnes.

In: European Urology, Vol. 61, No. 5, 2012, p. 865-74.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Orsted, DD, Nordestgaard, BG, Jensen, GB, Schnohr, P, Bojesen, SE & Ørsted, DD 2012, 'Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population', European Urology, vol. 61, no. 5, pp. 865-74. https://doi.org/10.1016/j.eururo.2011.11.007

APA

Orsted, D. D., Nordestgaard, B. G., Jensen, G. B., Schnohr, P., Bojesen, S. E., & Ørsted, D. D. (2012). Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population. European Urology, 61(5), 865-74. https://doi.org/10.1016/j.eururo.2011.11.007

Vancouver

Orsted DD, Nordestgaard BG, Jensen GB, Schnohr P, Bojesen SE, Ørsted DD. Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population. European Urology. 2012;61(5):865-74. https://doi.org/10.1016/j.eururo.2011.11.007

Author

Orsted, David D ; Nordestgaard, Børge G ; Jensen, Gorm B ; Schnohr, Peter ; Bojesen, Stig E ; Ørsted, David Dynnes. / Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population. In: European Urology. 2012 ; Vol. 61, No. 5. pp. 865-74.

Bibtex

@article{7118e84991734f60bfe64b2d6d708e6d,
title = "Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population",
abstract = "It is largely unknown whether prostate-specific antigen (PSA) level at first date of testing predicts long-term risk of prostate cancer (PCa) incidence and mortality in the general population.",
author = "Orsted, {David D} and Nordestgaard, {B{\o}rge G} and Jensen, {Gorm B} and Peter Schnohr and Bojesen, {Stig E} and {\O}rsted, {David Dynnes}",
note = "Copyright {\circledC} 2011 European Association of Urology. Published by Elsevier B.V. All rights reserved.",
year = "2012",
doi = "10.1016/j.eururo.2011.11.007",
language = "English",
volume = "61",
pages = "865--74",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "5",

}

RIS

TY - JOUR

T1 - Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population

AU - Orsted, David D

AU - Nordestgaard, Børge G

AU - Jensen, Gorm B

AU - Schnohr, Peter

AU - Bojesen, Stig E

AU - Ørsted, David Dynnes

N1 - Copyright © 2011 European Association of Urology. Published by Elsevier B.V. All rights reserved.

PY - 2012

Y1 - 2012

N2 - It is largely unknown whether prostate-specific antigen (PSA) level at first date of testing predicts long-term risk of prostate cancer (PCa) incidence and mortality in the general population.

AB - It is largely unknown whether prostate-specific antigen (PSA) level at first date of testing predicts long-term risk of prostate cancer (PCa) incidence and mortality in the general population.

U2 - 10.1016/j.eururo.2011.11.007

DO - 10.1016/j.eururo.2011.11.007

M3 - Journal article

C2 - 22104593

VL - 61

SP - 865

EP - 874

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 5

ER -

ID: 40162974